Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Polysaccharide From Eupolyphaga sinensis Walker With Anti-HBV Activities In Vitro and In Vivo. | Front Pharmacol | 2022 | 35308231 | PubTator, text mining | PubMed |
| Obesity and exercise training alter inflammatory pathway skeletal muscle small extracellular vesicle microRNAs. | Exp Physiol | 2022 | 35293040 | PubTator, text mining | PubMed |
| Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus. | Aliment Pharmacol Ther | 2022 | 35292991 | PubTator, text mining | PubMed |
| Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency. | JHEP Rep | 2022 | 35284810 | PubTator, text mining | PubMed |
| Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences. | Int J Mol Sci | 2022 | 35269929 | PubTator, text mining | PubMed |
| Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives. | J Clin Med | 2022 | 35268440 | PubTator, text mining | PubMed |
| Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 35267563 | PubTator, text mining | PubMed |
| The Effects of Common Genetic Variation in 96 Genes Involved in Thyroid Hormone Regulation on TSH and FT4 Concentrations. | J Clin Endocrinol Metab | 2022 | 35262175 | PubTator, text mining | PubMed |
| Characterization of Clofazimine as a Potential Substrate of Drug Transporter. | Antimicrob Agents Chemother | 2022 | 35254089 | PubTator, text mining | PubMed |
| The Traditional Uses, Phytochemistry, Pharmacokinetics, Pharmacology, Toxicity, and Applications of Corydalis saxicola Bunting: A Review. | Front Pharmacol | 2022 | 35250571 | PubTator, text mining | PubMed |
| Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer. | Int J Nanomedicine | 2022 | 35250267 | PubTator, text mining | PubMed |
| Combination therapy of ursodeoxycholic acid and glucocorticoid and (or) immunosuppressant in patients with primary biliary cholangitis: A meta-analysis. | Medicine (Baltimore) | 2022 | 35244071 | PubTator, text mining | PubMed |
| Serum bile acid response to oral glucose is attenuated in patients with early type 2 diabetes and correlates with 2-hour plasma glucose in individuals without diabetes. | Diabetes Obes Metab | 2022 | 35238131 | PubTator, text mining | PubMed |
| Hepatitis D: advances and challenges. | Chin Med J (Engl) | 2022 | 35234694 | PubTator, text mining | PubMed |
| Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System. | Viruses | 2022 | 35215970 | PubTator, text mining | PubMed |
| Structure-Based Discovery of N-Sulfonylpiperidine-3-Carboxamides as Novel Capsid Assembly Modulators for Potent Inhibition of HBV Replication. | Viruses | 2022 | 35215939 | PubTator, text mining | PubMed |
| Combination of Novel Therapies for HDV. | Viruses | 2022 | 35215860 | PubTator, text mining | PubMed |
| Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection. | Viruses | 2022 | 35215790 | PubTator, text mining | PubMed |
| New Kids on the Block: Bile Salt Conjugates of Microbial Origin. | Metabolites | 2022 | 35208250 | PubTator, text mining | PubMed |
| Metabolically Improved Stem Cell Derived Hepatocyte-Like Cells Support HBV Life Cycle and Are a Promising Tool for HBV Studies and Antiviral Drug Screenings. | Biomedicines | 2022 | 35203482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=45